Kite Wins EMA Recommendation To Market Tecartus For Leukemia Patients

 
• By Vibha Sharma

The European Medicines Agency has recommended new uses for six approved products, including the CAR T-cell therapy Tecartus. 

CAR T Therapy written in white chalk on a black chalkboard isolated on white
Tecartus is administered as a one-time infusion • Source: Shutterstock

More from Approvals

More from Product Reviews